Search

Search Constraints

You searched for: Subject Neoplasms -- Child

Search Results

34. Acquired neuro-secretory defect in growth hormone secretion due to Imatinib mesylate and the efficacy of growth hormone therapy in children with chronic myeloid leukemia. (17th February 2020)

39. Acute megakaryoblastic leukemia (excluding Down syndrome) remains an acute myeloid subgroup with inferior outcome in the French ELAM02 trial. (17th November 2017)